登录 注册 会员服务 联系我们

Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

  • Published:2007-11-07 Issue:11 Volume:2 Page:e1126
  • ISSN:1932-6203
  • Container-title:PLoS ONE
  • language:en
  • Short-container-title:PLoS ONE

Author:

Cox Helen S.,Kalon Stobdan,Allamuratova Sholpan,Sizaire Vinciane,Tigay Zinaida N.,Rüsch-Gerdes Sabine,Karimovich Hamraev A.,Kebede Yared,Mills Clair

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan;Clinical Infectious Diseases;2024-06-04

2. Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children;Clinical Epidemiology and Global Health;2024-05

3. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan;The International Journal of Tuberculosis and Lung Disease;2023-05-01

4. Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective;PLOS Global Public Health;2023-04-28

5. Factors affecting the success of MDR-TB treatment in high burden countries 2011-2021: A literature review;THE 6TH INTERNATIONAL CONFERENCE ON ENERGY, ENVIRONMENT, EPIDEMIOLOGY AND INFORMATION SYSTEM (ICENIS) 2021: Topic of Energy, Environment, Epidemiology, and Information System;2023
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3